Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Scalp microbiota changes may be linked to inflammation in Alopecia Areata.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

Higher apelin-12 levels may indicate more severe acne.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

Lower vitamin D levels are linked to more severe alopecia areata.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Trichoscopic evaluation is important for assessing hair loss in women.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Higher MPV and CRP levels may indicate more severe alopecia areata.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

AI is useful for diagnosing skin diseases but has limitations to consider before widespread use.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

miR-155-5p can help diagnose and track alopecia areata severity.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Male baldness is not significantly associated with coronary artery disease.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Severe alopecia areata may increase the risk of heart-related diseases.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.